Clinical canine Borrelia burgdorferi (sensu lato) infections are associated with highly elevated total IgG ELISA titers and convalescent Th2 immune responses

dc.contributor.authorHovius, K. Emil
dc.contributor.authorVan den Bergen, Tess
dc.contributor.authorAlmalik, Osama
dc.contributor.authorVersmissen, Ellen
dc.contributor.authorRutten, Victor P.M.G.
dc.contributor.authorSprong, Hein
dc.contributor.authorHovius, Joppe W.
dc.date.accessioned2025-11-25T12:11:42Z
dc.date.available2025-11-25T12:11:42Z
dc.date.issued2025-04-08
dc.description.abstractLyme disease is caused by Borrelia burgdorferi (sensu lato), which is transmitted through species belonging to the Ixodes ricinus complex. Canine Lyme Disease (CLD) is an established clinical entity in the USA. In Europe, an unambiguous diagnosis is rarely made, although it has been shown that dogs can be naturally infected and develop antibodies against B. burgdorferi (s.l.). The relation of Borrelia total IgG, IgG2, and IgG1 specific antibodies and the incidence of symptoms was studied in a prospective cohort study. In a tick-dense area in the Netherlands, 84 dogs in 4 age cohorts were followed up during 7 consecutive half-years. In addition, 31 Bernese Mountain dogs (BMD), known to have robust anti-Borrelia antibody responses, were clinically monitored and serologically examined. Generalized estimating equations (GEE) analysis on repeated half-year measurements of clinical and serological results showed a strong association between the clinical signs fever combined with lameness in time, which in turn was associated with transiently high total IgG titers and elevated IgG1 titers against B. burgdorferi (sensu stricto). In BMD, we observed seroconversions and persistence of specific high total IgG and IgG1 titers. Although the latter also developed a persistent reaction against the B. burgdorferi (s.l.) C6 peptide, their tissues tested negative for B. burgdorferi (s.l.) DNA. This study strongly suggests that dogs - not vaccinated against Borrelia spp. infections - that encounter yearly tick infestations are recurrently infected. Some breeds, such as Labrador Retrievers and BMD, in the course of multiple tick-infestation seasons, develop transient symptoms compatible with CLD. Symptoms were strongly associated with temporarily raised total IgG and concomitant or convalescent high IgG1 antibody responses against B. burgdorferi (sensu stricto). Our findings provide insights into the resistance of dogs against B. burgdorferi (s.l.) infections and show that transient symptoms of CLD only occur in a subset of infected dogs.
dc.description.departmentVeterinary Tropical Diseases
dc.description.librarianam2025
dc.description.sdgSDG-03: Good health and well-being
dc.description.urihttps://www.sciencedirect.com/journal/current-research-in-parasitology-and-vector-borne-diseases
dc.identifier.citationHovius, K.E., Van den Bergen, T., Almalik, O. et al. 2025, 'Clinical canine Borrelia burgdorferi (sensu lato) infections are associated with highly elevated total IgG ELISA titers and convalescent Th2 immune responses', Current Research in Parasitology & Vector-Borne Diseases, vol. 7, art. 100258, pp. 1-13. https://doi.org/10.1016/j.crpvbd.2025.100258.
dc.identifier.issn2667-114X (online)
dc.identifier.other10.1016/j.crpvbd.2025.100258
dc.identifier.urihttp://hdl.handle.net/2263/105489
dc.language.isoen
dc.publisherElsevier
dc.rights© 2025 The Authors. This is an open access article under the CC BY-NC-ND license.
dc.subjectDogs
dc.subjectBorrelia
dc.subjectCanine lyme disease (CLD)
dc.subjectDiagnosis
dc.subjectSeroconversion
dc.subjectIgG whole cell ELISA
dc.subjectIgG1
dc.subjectTicks
dc.subjectSeasons
dc.subjectLyme disease
dc.titleClinical canine Borrelia burgdorferi (sensu lato) infections are associated with highly elevated total IgG ELISA titers and convalescent Th2 immune responses
dc.typeArticle

Files

Original bundle

Now showing 1 - 5 of 5
Loading...
Thumbnail Image
Name:
Hovius_Clinical_2025.pdf
Size:
3.27 MB
Format:
Adobe Portable Document Format
Description:
Article
Loading...
Thumbnail Image
Name:
Hovius_ClinicalSuppl1_2025.pdf
Size:
299.89 KB
Format:
Adobe Portable Document Format
Description:
Supplementary Material 1
Loading...
Thumbnail Image
Name:
Hovius_ClinicalSuppl2_2025.xlsx
Size:
80.51 KB
Format:
Microsoft Excel XML
Description:
Supplementary Material 2
Loading...
Thumbnail Image
Name:
Hovius_ClinicalSuppl3_2025.xlsx
Size:
98.45 KB
Format:
Microsoft Excel XML
Description:
Supplementary Material 3
Loading...
Thumbnail Image
Name:
Hovius_ClinicalSuppl4_2025.xlsx
Size:
22.92 KB
Format:
Microsoft Excel XML
Description:
Supplementary Material 4

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: